Multi-component Real-time Remote Rehabilitation in Sarcopenia
Launched by WEST CHINA HOSPITAL · Apr 17, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying ways to help people with sarcopenia, a condition that involves loss of muscle strength and mass, which can affect balance and walking ability. The researchers want to compare two rehabilitation methods: one that provides real-time support remotely and another where participants manage their own exercise routines at home. By participating in this study, individuals will help determine which method is more effective in improving muscle strength, muscle mass, balance, and walking ability.
To be eligible for this trial, participants should be between the ages of 21 and 93 and meet specific criteria related to muscle strength, physical performance, and muscle mass as defined by the Asian Working Group for Sarcopenia. Those who have certain health conditions, have been regularly exercising, or have difficulty using the technology needed for the study may not qualify. Participants will sign a consent form before joining and can expect guidance throughout the trial, which aims to find better ways to support those with sarcopenia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- According to the diagnostic criteria for sarcopenia established by the Asian Working Group for Sarcopenia (AWGS):
- 1. Low muscle strength:
- • Handgrip strength \< 28 kg for men, \< 18 kg for women; and/or
- 2. Low physical performance:
- • Usual gait speed (6-Meter Gait Speed, 6MGS) ≤ 1.0 m/s; and/or
- 3. Low muscle mass:
- • Skeletal Muscle Mass Index (SMI) \< 7.0 kg/m² for men, \< 5.7 kg/m² for women.
- Exclusion Criteria:
- • 1. Unable or unwilling to undergo body composition measurement.
- • 2. Regular exercise habits within the past 6 months (resistance training ≥ 2 times/week, moderate-intensity aerobic exercise ≥ 3 times/week).
- • 3. History of unstable cardiovascular disease, stroke, diabetes, psychiatric disorders, or other contraindications to exercise in the past 6 months.
- • 4. Previously diagnosed with rheumatoid arthritis.
- • 5. History of conditions affecting motor coordination, such as poliomyelitis sequelae, epilepsy, or stroke sequelae.
- • 6. Presence of implanted medical devices due to previous fractures, heart disease, or other conditions.
- • 7. Diagnosis of malignant tumors.
- • 8. Unable to independently use the WeChat mini program used in this study.
About West China Hospital
West China Hospital, affiliated with Sichuan University, is a leading medical institution renowned for its comprehensive healthcare services, advanced research initiatives, and commitment to medical education. As a prominent clinical trial sponsor, the hospital leverages its extensive resources and expertise to facilitate innovative research in various therapeutic areas. With a focus on improving patient outcomes and advancing medical knowledge, West China Hospital collaborates with various stakeholders to conduct rigorous clinical trials that adhere to the highest ethical and scientific standards. Its state-of-the-art facilities and multidisciplinary teams ensure the successful execution of trials, contributing significantly to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Jian Li, MM
Study Director
Sports Medicine Center, West China Hospital, Sichuan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported